These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25347735)

  • 41. Transcriptional regulation of the 230-kDa bullous pemphigoid antigen gene expression by interferon regulatory factor 1 and interferon regulatory factor 2 in normal human epidermal keratinocytes.
    Odanagi M; Kikuchi Y; Yamazaki T; Kaneko T; Nakano H; Tamai K; Uitto J; Hanada K
    Exp Dermatol; 2004 Dec; 13(12):773-9. PubMed ID: 15560761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. APC inhibits ERK pathway activation and cellular proliferation induced by RAS.
    Park KS; Jeon SH; Kim SE; Bahk YY; Holmen SL; Williams BO; Chung KC; Surh YJ; Choi KY
    J Cell Sci; 2006 Mar; 119(Pt 5):819-27. PubMed ID: 16478791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response.
    Ahn DG; Sharif T; Chisholm K; Pinto DM; Gujar SA; Lee PW
    Cell Cycle; 2015; 14(14):2301-10. PubMed ID: 25946643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
    Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
    Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
    Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
    Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
    Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
    Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells.
    Kano S; Sato K; Morishita Y; Vollstedt S; Kim S; Bishop K; Honda K; Kubo M; Taniguchi T
    Nat Immunol; 2008 Jan; 9(1):34-41. PubMed ID: 18059273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes.
    Cho HJ; Kim SK; Jin SM; Hwang EM; Kim YS; Huh K; Mook-Jung I
    Glia; 2007 Feb; 55(3):253-62. PubMed ID: 17091494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
    Aref S; Castleton AZ; Bailey K; Burt R; Dey A; Leongamornlert D; Mitchell RJ; Okasha D; Fielding AK
    Mol Ther; 2020 Apr; 28(4):1043-1055. PubMed ID: 32087150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts.
    Kim S; Lee YZ; Kim YS; Bahk YY
    Proteomics; 2008 Aug; 8(15):3082-93. PubMed ID: 18601226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of IRF1 and IRF2 transcription factors in leukaemogenesis.
    Choo A; Palladinetti P; Passioura T; Shen S; Lock R; Symonds G; Dolnikov A
    Curr Gene Ther; 2006 Oct; 6(5):543-50. PubMed ID: 17073600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
    Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
    Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new transcription factor ATG10S activates IFNL2 transcription by binding at an IRF1 site in HepG2 cells.
    Zhang MQ; Zhao Q; Zhang JP
    Autophagy; 2020 Dec; 16(12):2167-2179. PubMed ID: 31996071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.
    Dery KJ; Silver C; Yang L; Shively JE
    J Biol Chem; 2018 Jun; 293(24):9277-9291. PubMed ID: 29720400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria.
    Rosain J; Neehus AL; Manry J; Yang R; Le Pen J; Daher W; Liu Z; Chan YH; Tahuil N; Türel Ö; Bourgey M; Ogishi M; Doisne JM; Izquierdo HM; Shirasaki T; Le Voyer T; Guérin A; Bastard P; Moncada-Vélez M; Han JE; Khan T; Rapaport F; Hong SH; Cheung A; Haake K; Mindt BC; Pérez L; Philippot Q; Lee D; Zhang P; Rinchai D; Al Ali F; Ahmad Ata MM; Rahman M; Peel JN; Heissel S; Molina H; Kendir-Demirkol Y; Bailey R; Zhao S; Bohlen J; Mancini M; Seeleuthner Y; Roelens M; Lorenzo L; Soudée C; Paz MEJ; González ML; Jeljeli M; Soulier J; Romana S; L'Honneur AS; Materna M; Martínez-Barricarte R; Pochon M; Oleaga-Quintas C; Michev A; Migaud M; Lévy R; Alyanakian MA; Rozenberg F; Croft CA; Vogt G; Emile JF; Kremer L; Ma CS; Fritz JH; Lemon SM; Spaan AN; Manel N; Abel L; MacDonald MR; Boisson-Dupuis S; Marr N; Tangye SG; Di Santo JP; Zhang Q; Zhang SY; Rice CM; Béziat V; Lachmann N; Langlais D; Casanova JL; Gros P; Bustamante J
    Cell; 2023 Feb; 186(3):621-645.e33. PubMed ID: 36736301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus.
    Dellac S; Ben-Dov H; Raanan A; Saleem H; Zamostiano R; Semyatich R; Lavi S; Witz IP; Bacharach E; Ehrlich M
    Int J Cancer; 2021 May; 148(9):2321-2334. PubMed ID: 33197301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response.
    Frontini M; Vijayakumar M; Garvin A; Clarke N
    Nucleic Acids Res; 2009 Mar; 37(4):1073-85. PubMed ID: 19129219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H-Ras Exerts Opposing Effects on Type I Interferon Responses Depending on Its Activation Status.
    Chen GA; Lin YR; Chung HT; Hwang LH
    Front Immunol; 2017; 8():972. PubMed ID: 28848563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.